Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered ALS-008176 Regimens in Adult Participants Hospitalized With Respiratory Syncytial Virus
Condition: Respiratory Syncytial Viruses
Interventions: Drug: ALS-008176; Drug: Placebo
Sponsor: Janssen Research & Development, LLC
Suspended - verified January 2017
Interventions: Drug: ALS-008176; Drug: Placebo
Sponsor: Janssen Research & Development, LLC
Suspended - verified January 2017